Noom Inc.
18
0
0
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 18 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
6%
1 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1
Role: collaborator
GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
Role: lead
Noom Health for Weight Management
Role: collaborator
Longitudinal Effects of a Commercial Digital Weight Management Program on Weight Loss
Role: lead
Improving Quality of Life in Men and Women With Overweight or Obesity
Role: lead
Effects of Online App Weight Loss Programs on Liver Health in Obese Adults
Role: lead
Noom Coach for Bariatric Surgery
Role: lead
Noom Coach for Bariatric Health
Role: lead
Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program
Role: lead
Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer
Role: lead
Coached or Non-Coached Weight Loss Intervention
Role: lead
Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors
Role: lead
Attitudes Toward Food During a Weight Loss Intervention
Role: lead
Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH
Role: collaborator
Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention
Role: lead
Noom Monitor for Binge Eating
Role: collaborator
Developing and Validating Clinical Efficacy for Obesity Digital CBT Model
Role: collaborator
Smartphone Technology and CBT-GSH in Binge Eaters
Role: collaborator
All 18 trials loaded